Skip to content

Study · Animal study (in vivo) · mouse · 1991

1 result

Tamoxifen-stimulated growth of human endometrial carcinoma.

Jordan VC, Gottardis MM, Satyaswaroop PG

Annals of the New York Academy of Sciences1 Jan 1991Cited by 19 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Safety outcome

    In athymic mice with human endometrial carcinoma, enclomiphene supported tumor growth as actively as tamoxifen.

    In plain wordsIn mice with human endometrial tumors, enclomiphene supported tumor growth as strongly as tamoxifen.

    Outcome
    Direction not reportedEndometrial tumor growth stimulation
    Study

    mousen: not reported in source

    athymic mice with human EnCa101 endometrial carcinoma
    Comparator
    tamoxifen
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Trioxifene, enclomiphene and nafoxidine are all as active as tamoxifen whereas the antiestrogen keoxifene, that has reduced estrogen-like properties, will partially inhibit tamoxifen-stimulated growth.
    2 context sentences
    Summary · context
    An estrogen receptor and progesterone receptor positive endometrial carcinoma (EnCa101) will grow in response to either estradiol or tamoxifen when transplanted into athymic mice.
    Summary · context
    We have tested several antiestrogens with different properties to determine their ability to support endometrial tumor growth.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.